Effect of Soy Milk on Metabolic Status of Patients with Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial

Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial

(2018) Sasan Amanat et al.   CLINICAL NUTRITION

Plant-based milk alternatives an emerging segment of functional beverages: a review

(2016) Swati Sethi et al.   JOURNAL OF FOOD SCIENCE AND TECHNOLOGY-MYSORE

Calcium Reduces Liver Injury in Mice on a High-Fat Diet: Alterations in Microbial and Bile Acid Profiles

(2016) Muhammad Nadeem Aslam et al.   PLoS One

Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome

(2015) Amedeo Lonardo et al.   DIGESTIVE AND LIVER DISEASE

Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives

(2015) Federico Salomone et al.   LIVER INTERNATIONAL

Effect of soy nuts and equol status on blood pressure, lipids and inflammation in postmenopausal women stratified by metabolic syndrome status

(2015) Subroto Acharjee et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Soy milk consumption, markers of inflammation and oxidative stress in women with rheumatoid arthritis: A randomised cross-over clinical trial

(2015) Majid Mohammad-Shahi et al.   Nutrition & Dietetics

Role of diet and nutritional management in non-alcoholic fatty liver disease

(2013) Jian-Gao Fan et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Soy Milk Consumption and Blood Pressure Among Type 2 Diabetic Patients With Nephropathy

(2013) Maryam Sadat Miraghajani et al.   JOURNAL OF RENAL NUTRITION

Whole soy, but not purified daidzein, had a favorable effect on improvement of cardiovascular risks: A 6-month randomized, double-blind, and placebo-controlled trial in equol-producing postmenopausal women

(2013) Zhao-min Liu et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: A parallel randomized trial

(2013) Ali Hashemi Kani et al.   NUTRITION

Soy Milk Consumption, Inflammation, Coagulation, and Oxidative Stress Among Type 2 Diabetic Patients With Nephropathy

(2012) M. S. Miraghajani et al.   DIABETES CARE

Isoflavones as a smart curer for non-alcoholic fatty liver disease and pathological adiposity via ChREBP and Wnt signaling

(2011) Mi-Hyun Kim et al.   PREVENTIVE MEDICINE

The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with diet-induced non-alcoholic fatty liver disease

(2010) Mi-Hyun Kim et al.   BRITISH JOURNAL OF NUTRITION

Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism

(2010) M-H Kim et al.   INTERNATIONAL JOURNAL OF OBESITY

Apparent bioavailability of isoflavones after intake of liquid and solid soya foods

(2009) Adrian A. Franke et al.   BRITISH JOURNAL OF NUTRITION

Definition and natural history of metabolic steatosis: histology and cellular aspects

(2009) V. Paradis et al.   DIABETES & METABOLISM